Ann: MLA Quarterly Update March 2017, page-17

Not sure on the downgrade piece, I might've missed something?  MLA does suffers from liquidity (as shown by the +/- 20%  daily SP movements) as there is a fair bit tied up by the top-20 holders. But all balance sheet metrics are pointing to a company producing solid growth profitably, I believe this year is the breakout year, and realistically could be seeing a share price of 8-10c by year end IMO.

The half year report also outlined prospects of several products hitting MLA's range which should see a bumper start to the next FY.

"User trials for a number of products, including DualCap®, AirQ and the Ardo range of breast pumps, are currently underway. Successful completion of these trials should see sales in the latter half of fiscal 2017"

all IMO, DYOR etc...